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Abstract
Background—Identity-by-descent (IBD) mapping using empirical estimates of IBD allele 
sharing may be useful for studies of complex traits in founder populations, where hidden 
relationships may augment the inherent genetic information that can be used for localization.
Methods and Results—Through IBD mapping, using ~400,000 SNPs, of serum lipid profiles 
we identified a major linkage signal for triglycerides (TG) in 1,007 Pima Indians (LOD=9.23, 
p=3.5×10−11 on chromosome 11q). In subsequent fine-mapping and replication association studies 
in ~7,500 Amerindians, we determined that this signal reflects effects of a loss-of-function 
Ala43Thr substitution in APOC3 (rs147210663) and 3 established functional SNPs in APOA5. 
The association with rs147210663 was particularly strong; each copy of the Thr allele conferred 
42% lower TG (β=−0.92±0.059 SD unit, p=9.6×10−55 in 4,668 Pimas and 2,793 Southwest 
Amerindians combined). The Thr allele is extremely rare in most global populations, but has a 
frequency of 2.5% in Pimas. We further demonstrated that 3 APOA5 SNPs with established 
functional impact could explain the association with the most well-replicated SNP (rs964184) for 
TG identified by genome-wide association studies (GWAS). Collectively these 4 SNPs account for 
6.9% of variation in TG in Pimas (and 4.1% in Southwest Amerindians), and their inclusion in the 
original linkage model reduced the linkage signal to virtually null.
Conclusions—APOC3/APOA5 constitutes a major locus for serum triglycerides in 
Amerindians, especially the Pimas, and these results provide an empirical example for the concept 
that population-based linkage analysis is a useful strategy to identify complex trait variants.
Correspondence: Wen-Chi Hsueh, PhD, National Institute of Diabetes & Digestive and Kidney Diseases, Building 1, 1550 E Indian 
School Rd., Phoenix, AZ 85014, wen-chi.hsueh@nih.gov.
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Genome-wide association studies (GWAS) of unrelated individuals have become popular 
approaches for identifying susceptibility genes for complex traits. A well-known drawback 
is that they require very large samples to detect the modest effect sizes often associated with 
single variants; furthermore, relevant functional variants must be well-captured by the 
genotyping platform. Analyses of related individuals can have advantages over those of 
unrelated individuals because they allow for the efficient detection of high-impact variants 
with a relatively small sample size and increased power for follow-up association studies.1 
Linkage studies, which analyze phenotypic similarity among related individuals with respect 
to identity by descent (IBD) in a given region, may efficiently detect regions which contain 
multiple functional variants and they do not require functional variants to be highly 
concordant with genotyped markers. However, conventional linkage studies have been 
limited by only analyzing allele sharing among individuals with known relationships. In 
recent years, methods have been developed to improve calculation of sharing of alleles IBD 
from dense genotypic data. These methods allow for the IBD calculation among individuals 
without known relationships (i.e., they are cryptically related). With this approach, one may 
considerably improve the efficiency of variance component IBD mapping (also known as 
population-based linkage analysis). This approach may be particularly appealing for studies 
in founder populations, as members of such populations tend to share longer chromosomal 
segments IBD with one another.2 In this study, we performed a population-based genome-
wide linkage study (GWLS) of serum lipid levels in 1,024 individuals from a founder 
population, the Pima Indians residing in the United States, who had previously participated 
in a GWAS.3 We were able to pinpoint specific functional variants explaining a very 
significant linkage signal for serum triglycerides (TG) through a four-stage study, including 




Much of the data were derived from a longitudinal community-based cohort study of type 2 
diabetes (T2D) conducted in Arizona, where most of the participants are Pima Indians (the 
Pima study).4 For the initial discovery involving GWLS, 1,024 Pima subjects, who had also 
participated in a GWAS3 with available lipid data, including total cholesterol, high-density 
lipoprotein cholesterol (HDL-C), TG and low-density lipoprotein cholesterol (LDL-C) 
measurements, were included (1,007 had TG measurements).
The first sample for replication studies included 5,491 (4,668 with TG data) additional Pima 
subjects who were not part of the initial discovery set and did not have GWAS data. Among 
these participants, 2,713 are full-heritage Pima Indians (defined as self-reported 8/8th Pima 
heritage) and another 2,778 subjects are, on average, 6/8th American Indian (typically 4/8th 
Pima and an additional 2/8th from other tribes). A subset of the Pima participants (n=296) 
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had whole genome sequence (WGS) data available, which were used to profile the genomic 
variations in this population.
A second set of samples for the replication studies came from the Phoenix extension of 
FIND (Family Investigation of Nephropathy and Diabetes), a multicenter study designed to 
identify genes involved in diabetic nephropathy and related traits. Eligible subjects 
(n=3,189; 2,793 with TG data) had ≥50% Amerindian heritage and most were urban-
dwelling Amerindians living in or near Phoenix. Table S1 (in the Data Supplement) shows 
characteristics of these 3 groups. Studies were approved by the Institutional Review Board 
of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and all 
participants provided written informed consent. Phenotypic measurements were based on 
standard protocols and are described in the Data Supplement.
Genotypic data ascertainment
Genotypes used in the linkage analysis (to calculate IBD sharing in the autosomal genome 
and to assess local IBD) were produced with the Affymetrix 6.0 Human SNP Array (see 
Methods in the Data Supplement). A total of 398,430 autosomal SNPs passed quality control 
checks and were used in subsequent analyses. As part of our fine-mapping studies, we used 
WGS data of 296 Pima Indians for variant discovery and imputation. The WGS data were 
generated by Illumina (San Diego, CA) at a coverage of 30–40X.
Genotyping of single nucleotide polymorphisms (SNPs) in both replication sets used a 
variety of genotyping approaches, which are described in detail in the Data Supplement. In 
addition, 45 selected ancestry informative markers with large differences in allele frequency 
between Amerindian and European populations5 were genotyped and used to control for 
population admixture in replication samples, in which GWAS data were not available.
Statistical analyses
Estimation of the percentage of alleles shared IBD—The execution of variance 
components linkage analysis of quantitative traits requires information on the alleles shared 
IBD between 2 individuals. We used the program Beagle6 and genetic maps from the 
Hapmap project to carry out IBD estimation at each of ~400,000 SNPs; this program 
estimates IBD from haplotypic similarity based on a hidden Markov model that takes 
recombination and linkage disequilibrium (LD) among SNPs into account. More details 
regarding the parameter settings and calculation are provided in the Data Supplement.
GWLS of 4 lipid traits: All traits were normalized by inverse Gaussian transformation prior 
to analysis. Linkage analysis was conducted using the principles of the variance-components 
method developed by Amos7 and carried out using SAS (SAS Institute, Cary, NC; see 
Methods in the Data Supplement). For computational efficiency, we carried out linkage 
analysis at every 50th variant across the genome, after which the maximum LOD (max LOD) 
was determined. In other words, ~8,000 tests (at ~0.44 cM intervals) were carried out.
Since we used the IBD matrix generated from the Beagle estimates among all 523,776 pairs 
of individuals in the sample, instead of those from known relationships, the present study is 
termed a population-based linkage analysis.
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Fine-mapping study – association analysis conditional on linkage effects—To 
identify whether association with specific genetic variant(s) may explain the observed 
linkage signals, we carried out association analyses conditional on linkage effects (i.e. 
accounting for random effects of both local and global IBD) to evaluate the association of 
variants under the linkage peak in the 1,024 subjects used in linkage analyses. The region of 
interest was defined as the “2-LOD” support interval (i.e., the interval in which the LOD is 
within 2 units of the max LOD). Sources of genotypic data used in these analyses are 
described in the Data Supplement. To account for the relatedness among family members in 
the analyses, we used the measured genotype approach,8 in which the genotypic effects are 
incorporated as fixed effects in the mixed model. In an effort to identify genetic variants 
with distinct effects, variant(s) with stronger association(s) were included as covariate(s) in 
the next round of analysis, until no significant association was observed (i.e. p value <0.05 
corrected for multiple comparisons, see Methods in the Data Supplement).
Replication association analyses of TG—Replication studies were carried out in 2 
stages. First, we conducted the replication study in Pima Indians (the Pima sample, n=4,668 
after exclusion of those in the GWLS). If any associations were replicated, we conducted a 
second replication study using 2,793 Amerindian samples from FIND). Detailed statistical 
approaches and meta-analysis methods are described in the Data Supplement. Because 
variants examined were from a small region of the genome with a high density of variants 
where extensive LD was present, we corrected for multiple comparisons using the approach 
suggested by Moskvina and Schmidt9 (more details in the Data Supplement). All presented 
p values for the fine-mapping and replication studies are corrected p values.
Haplotype construction and analyses—Once we identified multiple variants within a 
small gene with strong association with TG, we carried out haplotype analysis to assess 
associations conditional on specific allelic backgrounds constituting ≥2 SNPs (see the Data 
Supplement for details).
Covariates (population admixture estimates, type 2 diabetes status and sex) used in all 
models are described in the Data Supplement. Population admixture estimates used in the 
linkage studies were obtained using principal components analysis, and those used in the 
replication studies were calculated as Amerindian heritage based on 45 ancestry informative 
markers. Details are described in the Data Supplement.
RESULTS
Empirical IBD estimates
Among the 1,024 subjects in the GWLS, the average estimated IBD across the genome 
ranged from 0.00001 to 0.57 for 523,776 pairs of subjects. Pairs with no known relationship 
(98.2% of all pairs) had a mean IBD of 0.02±0.01 (median=0.02). In contrast, the mean IBD 
for 171 pairs of individuals of white ethnicity genotyped with the same SNP array was 
0.0009±0.0007 (median=0.0008), suggesting that average relatedness among Pimas was 
much greater. A plot showing the estimated empirical IBD sharing by the expected 
relatedness is shown in the Data Supplement (Figure S1).
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Among 4 lipid traits analyzed, significant linkage (max LOD≥3) was identified for TG and 
HDL-C. The max LOD for TG was 9.23 (p=3.5×10−11) on chromosome 11q23, explaining 
10.6% of phenotypic variance (after accounting for effects of covariates), and the max LOD 
for HDL-C was 3.77 (p=1.5×10−5) on chromosome 1p, explaining 7.5% of the variance 
(Table S2 and Figure S2 in the Data Supplement). When the same analysis was conducted 
using only pairs with known self-reported relationships (n=9,664), the max LOD for TG was 
still observed in the same genomic region, however, with a much reduced significance 
(LOD=3.24, p=5.6×10−5) (Figure 1A). A similar reduction in LOD was observed for HDL-
C, and the max LOD was 2.55 (Figure 1B). We further refined the location of the max LOD 
by running additional linkage analyses at 5-SNP intervals within the 2-LOD region. This 
resulted in max LOD of 9.32 (explaining 10.8% of the variance ) and 4.05 (explaining 7.9% 
of the variance), for TG and HDL-C respectively. These refined max LOD locations were 
used to define genomic regions investigated in subsequent fine-mapping studies.
We also conducted a GWAS of these traits in the same sample, and observed associations for 
TG with SNPs in 11q23 at genome-wide significance (Figure S3 in the Data Supplement). 
The strongest association was with rs4417316, an intronic SNP in ZPR1 (p=1.8×10−10), but 
rs964184, the most commonly reported GWAS SNP for TG observed in multiple 
populations, also was strongly associated (p=4.0×10−8). The associations of all SNPs in this 
region were attenuated to p >10−5 after adjusting for the effects of rs964184. Thus, it 
appeared that the GWAS associations in Pimas largely reflected the effect of the established 
SNP rs964184. In contrast, linkage analyses of TG conditional on the effect of rs964184 or 
rs4417316 showed significant residual effect (LOD=6.02 and 4.80, respectively), suggesting 
the possibility of multiple variants in the region.
Fine-mapping study: association analyses of TG and HDL conditional on linkage effect
We performed imputation, using WGS data from 296 Pimas as the reference, and we 
conducted fine-mapping of the 2-LOD support interval for both regions by testing 
association conditional on the peak linkage signal in the same 1,024 samples used in GWLS. 
We selected the variant with the strongest association and analyzed associations of 
additional variants conditional on this strongest association; this procedure was repeated 
until no statistically significant associations were observed. For TG, after 4 rounds of 
analyses of 3,450 variants in a 1.81Mb region on 11q23, we identified 3 variants with 
distinct and significant associations (Table 1). The SNP with the strongest association with 
TG was rs147210663 explaining 6.9% of the variance (p=1.6×10−13) (Table 1). This SNP is 
in the apolipoprotein C3 gene (APOC3) at codon 43 (Ala → Thr substitution, or A43T); the 
minor allele codes for the Thr residue and has a frequency of 2.6% in GWLS. The SNP with 
the second strongest association with TG was rs2072560 after adjusting for the effect of 
rs147210663 (p=0.00028). This SNP resides in intron 3 of the apolipoprotein A5 gene 
(APOA5) but has no known function. The third variant with a significant association was 
rs11357208 after adjusting for the effects of 2 previous SNPs (p=0.0049). This insertion-
deletion variant residesin intron 5 of the SIK family kinase 3 gene (SIK3) without any 
known function. For HDL-C, no significant association was identified with any variant in the 
2-LOD support interval on chromosome 1p.
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Replication association analyses of TG
To confirm and further characterize the associations identified in the fine-mapping study, we 
analyzed the 3 distinctly associated TG variants, along with their tags (r2>0.8 in Pima WGS 
data) and nearby established TG-associated SNPs selected from published data. These 
studies were conducted in 2 different samples, namely 1) additional Pimas from the same 
parent study who were not part of GWLS (n=4,668, the Pima sample) and 2) southwestern 
urban Amerindians from the FIND sample (n=2,793). We, thus, analyzed 11 SNPs, 
including 6 established TG-associated SNPs (collectively called “GWAS SNPs”, including 
rs964184, rs3135506, rs651821, rs662799, rs12225230, and rs139961185).10–19 As shown 
in Table 1, there was no tag SNP for rs147210663 nor rs11357208. The SNP rs2072560 had 
3 tag SNPs (one of them, rs651821, was also identified in several published GWAS reports). 
As in the fine-mapping study, several rounds of analysis were conducted, with association 
examined conditional on the strongest variants identified in previous rounds. In the Pima 
sample, the association with the APOC3 A43T SNP strongly replicated (rs147210663, 
p=7.4×10−48), as did the 2nd variant (represented by rs651821, p=0.0012) (Table 2 and Table 
S3 in the Data Supplement). In addition, we also observed a strong association with a 
GWAS SNP (rs964184, p=2.1×10−22) distinct from rs147210663. The variant rs11357208 
did not show an association distinct from rs147210663, rs964184 and rs651821. However, as 
rs964184 was in moderate LD with both rs651821 and rs11357208 (r2=0.20 and 0.45, 
respectively), this may partially explain the lack of replicated association with rs11357208. 
In the second replication study (the FIND sample), we also observed distinct associations 
with rs964184 (1.4×10−10) and rs147210663 (p=6.3×10−7). Of note, the frequency of the 
Thr allele of rs147210663 in the FIND sample was much lower than that in the Pima sample 
(1% vs. 2.5%). Taken together, we replicated 2 distinct associations (with rs147210663 and 
rs964184).
Determining whether known functional variants account for the observed association with 
rs964184
The “GWAS” SNP rs964184 resides near the 3’UTR of the zinc finger gene (ZPR1, also 
known as ZNF259), but evidence for a functional effect of this SNP is lacking. Two 
“haploblocks” (see methods) encompassing 3 SNPs (rs964184 and rs651821 identified in 
the replication studies, and rs2072560 identified from fine-mapping analyses) harbor 2 
genes: ZPR1 and APOA5. APOA5 is expressed solely in liver tissues, the key organ for lipid 
metabolism, whereas ZPR1 is expressed ubiquitously. APOA5 has a known role in TG 
metabolism, and has a SNP (rs651821) significantly associated with TG. Therefore, we 
extended our association study to investigate if other functional variants in these 2 genes 
may explain the observed association with rs964184. Based on Pima WGS data, 4 SNPs in 
APOA5 were previously documented to be functional20–23 with a minor allele frequency 
(MAF) ≥1%: rs2266788, rs3135506, rs651821 and rs662799. We tested associations 
between TG and these SNPs to examine the extent to which they explained the association 
of rs964184 with TG. As shown in Figure 2, in the Pima sample, rs964184 (dark bars) 
accounted for 2.2% of the trait variance with p=5.7×10−23 when no APOA5 SNP was 
included in the model (conditioning on the effect of rs147210663 and other covariates). This 
effect was gradually diminished with the addition of more APOA5 SNPs. When 3 APOA5 
SNPs (rs651821, rs3135506, rs2266788) were included, they accounted for 2.4% of the 
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variance (p=1.2×10−22) collectively, whereas the effect of rs964184 was reduced to 0.07% 
(p=0.015). The addition of rs662799 (r2=0.96 with rs2266788), did not contribute 
significantly beyond other APOA5 SNPs. We also conducted similar analyses of all SNPs in 
the exons or UTRs of ZPR1 (rs61905116, rs144966144, and rs35120633, identified in our 
Pima WGS data). The effects of rs964184 on TG remained highly significant after adjusting 
for all 3 SNPs. In addition, although our study populations had a high T2D prevalence, the 
genetic associations with these SNPs in APOC3 and APOA5 were observed in those with or 
without diabetes (data not shown). The exclusion of subjects taking antilipidemic 
medications (~5%) from analyses did not affect any results significantly (data not shown).
Haplotype analyses of APOA5 SNPs
Assessment of the distinct contribution of 3 APOA5 SNPs is difficult because they are in LD 
(r2=0.04–0.75, Figure S4 in the Data Supplement) and their statistical associations may be 
codependent when their effects are assessed individually. Therefore, we carried out analysis 
of haplotypes composed of these 3 SNPs to better evaluate allelic effects of each of these 
SNPs relative to the allelic background of other 2. Previous studies have described three 
common haplotypes at these SNPs: APOA5*1 containing the TG-lowering allele at all 3 loci 
(T-Ser-A for rs2266788-rs3135506-rs651821), APOA5*2 containing the TG-raising allele at 
rs2266788 and rs651821 (C-Ser-G), and APOA5*3 containing the TG-raising allele only at 
rs3135506 (T-Trp-A). In East Asian populations, an additional haplotype (APOA5*4) 
containing only one TG-raising allele (at rs651821, T-Ser-G) has been observed.24 In the 
Pimas we found that *1, *2 and *3 were common haplotypes and we observed an additional 
haplotype with frequency of 3.6% which contains the TG-raising allele at rs2266788 only 
(C-Ser-A, which we call APOA5*5). Given the same allelic background at the other 2 SNPs, 
distinct allelic effects of all 3 APOA5 SNPs were statistically significant (Table 3). For 
instance, compared with the allelic background of rs2266788 and rs651821 (reference 
haplotype: APOA5*1), the APOA5*3 haplotype, which differs only at the minor allele of 
rs3135506, was still significantly associated with higher TG (p=1.3×10−12). Furthermore, 
compared with APOA5*1, APOA5*2, which differs at rs651821 and rs2266788 was 
associated with significantly higher TG (p=2.2×10−23). The haplotypic associations were 
replicated in the FIND sample with the exception of the comparison of APOA5*2 with 
APOA5*5, whose borderline significance was likely due to the low frequency of APOA5*5 
(0.5%).
Final linkage-and-association model fitting
From replication studies, we identified the APOC3 A43T SNP (rs147210663) and 3 APOA5 
SNPs (rs2266788, rs3135506 and rs651821), which are well-established as functional, as 
having significant influences on TG. Their effects all appeared additive (Figure S5 in the 
Data Supplement). Therefore, we included these 4 SNPs as covariates in the original linkage 
model (n=1,007 Pimas) and assessed the extent to which these 4 SNPs explain the linkage 
signal. As shown in Table 4, the APOC3 43T SNP alone reduces the LOD from 9.32 to 2.24. 
When we added 3 APOA5 SNPs to the model, the collective effect of these 4 SNPs reduced 
the remaining linkage signal to LOD of 0.08 (residual variance explained=1.4% after 
accounting for the effects of 4 SNPs and all covariates). In other words, these 4 SNPs 
virtually explained the linkage signal on 11q23 for TG.
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Although GWAS in unrelated individuals has been successful in identifying common 
variants associated with complex traits, family-based studies, such as IBD mapping (linkage) 
analysis, may have advantages in some situations, such as when the functional variants are 
not well-captured in the standard GWAS array. In this study, we used an IBD mapping 
approach in a founder population to identify genomic region(s) harboring substantial genetic 
effects on lipid levels. Estimating IBD empirically using dense genotypic data, we 
performed linkage analysis using all possible pairs within our study sample.
Using this approach, we identified a significant linkage signal with LOD=9.23 for TG in our 
GWLS. Through subsequent fine-mapping and 2 sets of replication studies, we identified 2 
SNPs (rs147210663 and rs964184) with significant and distinct associations with TG. One 
replicated SNP (rs964184) has no known function and is located near the 3’UTR of ZPR1. 
Little evidence has been found to indicate ZPR1’s influence on lipid metabolism despite 
rs964184 being the most widely replicated GWAS SNP for TG. Thus, we focused on 
variants in the only other candidate, APOA5. APOA5 variants have been extensively studied 
functionally due to the protein’s importance in TG metabolism. From Pima WGS data, we 
identified 4 SNPs in APOA5 with strong functional evidence from literature. We showed 
that the effect of rs964184 could be mostly explained by 3 of these APOA5 SNPs (the 4th 
SNP is in almost perfect LD with one of these 3). In other words, we consider it highly 
likely that rs964184 acts as a marker for the aggregate effect of these 3 SNPs with known 
effects on APOA5. Collectively, the APOC3 A43T SNP and the 3 strongly-associated 
functional SNPs in APOA5 explained most of the linkage signal.
The APOC3 A43T SNP had the strongest association with TG, and had an effect size (β=
−0.92±0.64 SD unit for the minor allele Thr, which corresponds to a 42% reduction in TG) 
among the largest reported for any complex trait.25 Its effect accounted for 4.7% of the 
variance of TG despite a fairly low frequency of the Thr allele (2.5%) in Pimas. It was also 
significantly associated with other lipid traits and lipid fractions, including with higher 
HDL-C and lower TG contained in very low density lipoprotein particles (VLDL-TG) (Table 
S3 in the Data Supplement). The Thr allele is rare in most other populations, with an MAF 
of ~1% in the other Southwest Amerindians, and very rare in most non-Amerindians with a 
collective frequency of 0.3% in phase 3 data from the 1000 Genomes Project (www.
1000genomes.org). The A43T SNP was initially identified in two Mayan Indians with low 
TG and APOC3 levels (where it was denoted as A23T).26 Strong associations between TG 
and rare non-synonymous SNPs (nsSNPs) in APOC3 have been observed in other 
populations as well, with loss-of-function variants conferring lower TG levels. Such an 
association was first suggested by a fine-mapping study following a GWAS in the Amish,27 
in whom a premature stop codon (R19X, rs76353203) which is rare in most populations, had 
frequency of 2.8% and was strongly associated with low TG levels. This same SNP was also 
identified as strongly associated with low TG levels in a Greek population isolate, in whom 
its frequency was 1.9%.28 Subsequently, several large sequencing or candidate gene studies 
have also provided evidence for strong protective effects of loss-of-function mutations in 
APOC3 on TG and cardiovascular diseases;28–33 these variants included the A43T SNP, but 
were tested for association in aggregate. The present study shows that the A43T SNP is 
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relatively common in some Amerindian populations (particularly Pimas), among whom the 
association achieves genome-wide statistical significance.
APOC3 is a small gene with 4 exons and 297 nucleotides. The protein is synthesized mainly 
in the liver, and strongly inhibits hepatic uptake of VLDL-C and intermediate density 
lipoproteins. Intracellularly, it promotes hepatic VLDL-C assembly and secretion.34 
Extracellularly, it attenuates hydrolysis and clearance of triglyceride-rich lipoproteins 
(TRLs) and impairs the lipolysis of TRLs by inhibiting lipoprotein lipase and the hepatic 
uptake of TRLs by remnant receptors.34 Recently, inhibitors of APOC3 synthesis have been 
shown to reduce hypertriglyceridemia.35 The sequence of APOC3 has been extensively 
determined in large and diverse samples. In the Pimas, there is only 1 nsSNP (A43T) 
identified in 296 samples. Findings from in vitro studies show that this A→T substitution 
probably alters the structure of APOC3, and leads to loss of its function in promoting the 
assembly and secretion of triglyceride-rich VLDL from hepatic cells.36 Also it has been 
shown that, it has less efficient lipid binding capacity; this leads to faster catabolism of 
APOC3 and less competition with APOE. This in turn is responsible for enhanced clearance 
of TG rich lipoproteins and lower plasma TG levels.26 Given all available statistical, 
functional, and physiological evidence, and the observation that the A43T SNP has no tag 
SNP, we consider that this SNP is likely a causal variant for TG.
In our replication studies, the SNP with the second strongest association with TG was 
rs964184. It is one of the most well-replicated SNPs from many large lipid GWAS, with 
particularly strong associations for TG.10, 12–15, 19, 25, 37, 38 Previous studies in Amerindian-
derived populations have identified strong associations between TG and variants in this 
chromosomal region, particularly rs964184.14, 19, 39 SIK3 has been suggested as a functional 
candidate based on evidence for recent natural selection centered on rs139961185.19 In our 
study, however, rs139961185 was not associated with TG after conditioning on rs964184 
(Table S3 in the Data Supplement). BUD13 and ZNF259 have also been implicated, based 
largely on the strong association with the nearby rs964184.14, 39 The SNP rs964184 is also 
near APOA5, however, and 4 common APOA5 SNPs (rs2266788, rs3135506, rs651821, 
rs6622799) have well-documented functional effects on APOA5. The only nsSNP of these 4 
is rs3135506 (S19W) which impairs protein translocation and secretion,20, 21 whereas 
rs651821 is located in the promoter region, and rs2266788 is located in the 3’ UTR of 
APOA5, a functional target site for a liver-expressed microRNA gene miR-485-5p. Our 
findings provided statistical evidence to implicate 3 functional SNPs (rs651821, rs3135506, 
and rs2266788) in APOA5 that explained almost all of the association of rs964184 with TG, 
contributed distinct effects, and that reduced the original linkage signal to virtually null. It 
should be noted that our findings are in concordance with functional studies that suggest 
distinct effects of each of these SNPs (Table 3, Figure 2). These 3 APOA5 SNPs all have 
elevated MAFs in Pimas (0.14–0.20, vs. 0.06–0.08 in whites), which resulted in increased 
statistical power in our study populations. One caveat is that as the 4th putatively functional 
SNP, rs6622799, is in almost perfect LD with rs2266788 (r2=0.96), their effects are not 
statistically distinguishable in our study populations.
Many studies have reported associations of haplotypes composed of these APOA5 
functional variants with TG. In 2001, Pennacchio et al. reported that the APOA5*2 
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haplotype, defined by the minor alleles of 3 SNPs (encompassing multiple functional 
variants rs662799–rs651821–rs2266788), was associated with elevated TG levels,40 and 
similar observations were replicated in multiple populations.24, 41–43 In some GWAS, these 
SNPs were individually reported as significant.11, 17, 44 Our study identified these same 
SNPs in a systematic approach, and provides additional support for multivariant influences 
from APOA5 on TG. In vitro studies suggest that all 3 SNPs have functional effects,22 but 
separate effects are difficult to observe in vivo because of the high degree of LD. With the 
additional haplotypic information available in the present study, we provide evidence for 
distinct effects of rs651821, rs3135506 and rs2266788/rs662799 on TG in vivo, and 
associations with the haplotypes APOA5*2 and APOA5*3 (representing rs3135506) achieve 
genome-wide statistical significance. Although these 3 APOA5 SNPs were only in moderate 
LD with rs964184 individually (r2=0.25–0.40, Figure S4 in the Data Supplement), the 
haplotypes comprised of any minor (TG-raising) allele of APOA5 SNPs were in strong LD 
with the minor allele of rs964184 collectively (r2=0.97) (Figure S6 in the Data Supplement), 
and, thus, the APOA5 SNPs can largely account for the association of rs964184 with TG in 
Amerindians. Based on analysis of data from the 1000 Genomes project (www.
1000genomes.org), it is noteworthy that rs964184 is similarly highly concordant with 
haplotypes containing a TG-raising allele at these APOA5 SNPs in populations 
representative of those where rs964184 was identified as a top GWAS SNP (e.g. r2=0.96 in 
CEU and GIH, r2=0.82 in CHB and MXL); thus these APOA5 SNPs might explain the 
association between rs964184 and TG in other populations as well. The role of APOA5 in 
influencing TG levels is supported by recent human sequencing studies showing rare 
deleterious APOA5 mutations associated with TG.45 Given statistical, functional and 
physiological evidence, we conclude that rs964184 is likely a marker for the collective 
effects of APOA5 functional SNPs on TG.
The linkage analysis results provide a context for interrogating whether multiple sources of 
genetic effect exist in the same genomic region. In our GWAS using the same 1,007 
subjects, we observed associations for TG with SNPs on 11q23 at genome-wide statistical 
significance, but these associations were greatly attenuated after adjustment for the 
established variant, rs964184. On the other hand, substantial residual linkage remained after 
adjustment for the effects of rs964184, and this served as the impetus for more detailed 
investigation of the region. Although computational tools for the IBD calculations required 
for population-based linkage analyses are available in several software packages, the method 
has not been widely-used. Our results suggest it can provide complementary information to 
a standard GWAS approach.
An advantage of the population-based linkage approach is that, in contrast to association 
analysis, it retains power even when the variants on the genotyping array are not highly 
concordant with a functional variant. The approach may be especially useful for identifying 
regions with susceptibility variants not well-captured by the genotyping platform (which 
will often be of low frequency) or identifying regions containing multiple susceptibility 
variants. For the 11q23 region identified here as linked with TG, both situations apply. The 
method uses information from all pairs of individuals in the population, and this remarkably 
enhances the statistical power, compared with conventional pedigree-based linkage analysis, 
particularly in populations recently descended from a small number of founders, in which 
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many individuals without known relationships may share large genomic segments IBD. The 
approach may be less useful in outbred populations, however. Power of the linkage approach 
is limited, compared with conventional association analysis, in the situation where a single 
functional variant, which is well-captured by the genotyping array, drives the association. A 
further limitation of the present study is that, with the limited sample size of GWLS, only 
relatively strong effect sizes are detectable; we estimate the detectable effect size is 9.7% of 
the variance for LOD>3 with 80% power (our linkage signal for TG had an effect size of 
10.8% of the variance).
In conclusion, we carried out a population-based GWLS of serum lipids and subsequently 
identified 4 SNPs with known functional effects in 2 apolipoprotein genes (APOC3 and 
APOA5) that influence TG levels. These findings suggest that population-based GWLS may 
provide complementary information to GWAS, particularly in founder populations. 
Identification of the TG-lowering nsSNP in APOC3 (A43T) was facilitated by population-
specific WGS data, which allowed for accurate imputation of this variant despite its low 
frequency, and the fact that it was not on the GWAS array (this SNP could not be captured 
by imputation using the 1000Genome data as the reference panel). The APOC3 A43T SNP 
has been established as a loss-of-function variant leading to lower TG based on a small 
number of previously described individuals and functional studies. By uncovering a founder 
effect in the Pimas for this SNP, we now provide population level data that unequivocally 
establish the TG-lowering properties of this SNP. Thus, the linkage signal we detected 
represents effects of both an established TG variant (rs964184) and a “novel” variant 
(A43T), not captured by standard GWAS arrays. We also provide evidence for 3 functional 
APOA5 SNPs exerting distinct and additive effects on TG. The association between 
rs964184 and TG has been replicated in multiple populations; our study demonstrates that 
rs964184 is likely a marker tagging aggregate effects of 3 functional SNPs in APOA5, at 
least in Amerindians. Thus, a single well-replicated GWAS signal can reflect the effects of 
multiple functional variants. Taken together, the APOC3 and APOA5 SNPs account for 
6.9% of the variation in TG, an effect which constitutes a major locus in Pimas. Our findings 
provide an empirical example for the concept that population-based linkage analysis, 
particularly in founder populations, can be useful for studies of complex traits.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Identity-by-descent mapping using empirical estimates of allele sharing between all pairs 
of individuals may be powerful in founder populations, where hidden relationships may 
augment the inherent genetic information that can be used for gene localization. We 
tested the usefulness of this approach by analyzing lipid profiles in 1,024 Pima Indians, a 
relatively genetically homogeneous population. We identified a major locus for serum 
triglycerides (p=2.9 10–11 on chromosome 11q). In multi-stage follow-up analyses using 
~9,000 subjects, we determined that this signal reflects effects of an Ala43Thr 
substitution in the APOC3 gene, and 3 established functional genetic variants in the 
APOA5 gene, collectively accounting for 6.9% of variation of triglyceride levels in 
Pimas. We further demonstrated that these 3 APOA5 variants could explain the 
association with the well-established variant for triglycerides levels, rs964184. This study 
provides a proof of concept that identity-by-descent mapping can be a useful strategy to 
identify causal variants affecting complex traits. The identification of these genes and 
specific genetic variants that affect an important risk factor for cardiovascular diseases 
(CVD) may contribute to the development of novel CVD interventions.
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Linkage study results of serum lipids showing the maximum LOD>3. (A) Results of 
triglycerides on chromosome 11; (B) Results of HDL-cholesterol on chromosome 1
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The impact of APOA5 SNPs on the association between rs964184 and serum triglycerides in 
the Pima sample. The top panel shows the % variance (%σ2) of triglycerides explained by 
rs964184 (black bars, conditional on any APOA5 SNPs) and the % σ2 resulting from the 
addition of the APOA5 SNPs (gray bars) to the statistical model. The bottom panel shows 
the significance of association (log(p)). Covariate effects adjusted included age, sex, diabetes 
status and rs147210663 genotypes. The order of APOA5 SNP addition was determined by 
their association significance conditioning on effects of SNPs with stronger effects. The p 
values for the APOA5 SNP associations were calculated with the df equal to the number of 
SNPs in the model.
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Table 4






p for all SNP
effects
Linkage only 9.32 10.8% ---- ----
APOC3 SNP effect 2.24 6.2% 6.9% 1.9 × 10−13
APOC3 + 3 APOA5 SNP effects 0.08 1.4% 9.1% 2.1 × 10−12*
*
The p value was determined based on a 4-df test.
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